286 related articles for article (PubMed ID: 29721762)
1. Effects of Diet on Bile Acid Metabolism and Insulin Resistance in Type 2 Diabetic Rats after Roux-en-Y Gastric Bypass.
Shan CX; Qiu NC; Liu ME; Zha SL; Song X; Du ZP; Rao WS; Jiang DZ; Zhang W; Qiu M
Obes Surg; 2018 Oct; 28(10):3044-3053. PubMed ID: 29721762
[TBL] [Abstract][Full Text] [Related]
2. Effect of Roux-en-Y gastric bypass surgery on bile acid metabolism in normal and obese diabetic rats.
Bhutta HY; Rajpal N; White W; Freudenberg JM; Liu Y; Way J; Rajpal D; Cooper DC; Young A; Tavakkoli A; Chen L
PLoS One; 2015; 10(3):e0122273. PubMed ID: 25798945
[TBL] [Abstract][Full Text] [Related]
3. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
[TBL] [Abstract][Full Text] [Related]
4. Roux-en-Y gastric bypass restores islet function and morphology independent of body weight in ZDF rats.
Mosinski JD; Aminian A; Axelrod CL; Batayyah E; Romero-Talamas H; Daigle C; Mulya A; Scelsi A; Schauer PR; Brethauer SA; Kirwan JP
Am J Physiol Endocrinol Metab; 2021 Feb; 320(2):E392-E398. PubMed ID: 33427046
[TBL] [Abstract][Full Text] [Related]
5. Expedited Biliopancreatic Juice Flow to the Distal Gut Benefits the Diabetes Control After Duodenal-Jejunal Bypass.
Han H; Wang L; Du H; Jiang J; Hu C; Zhang G; Liu S; Zhang X; Liu T; Hu S
Obes Surg; 2015 Oct; 25(10):1802-9. PubMed ID: 25726319
[TBL] [Abstract][Full Text] [Related]
6. Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague-Dawley Rat Model.
Dolo PR; Yao L; Li C; Zhu X; Shi L; Widjaja J
Obes Surg; 2018 May; 28(5):1313-1320. PubMed ID: 29098544
[TBL] [Abstract][Full Text] [Related]
7. Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1.
Liu Y; Zhou Y; Wang Y; Geng D; Liu J
Obes Surg; 2011 Sep; 21(9):1424-31. PubMed ID: 21479766
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN
Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
[TBL] [Abstract][Full Text] [Related]
9. Impact of the hepatic branch of the vagus and Roux-en-Y gastric bypass on the hypoglycemic effect and glucagon-like peptide-1 in rats with type 2 diabetes mellitus.
Qiu NC; Zhang Q; Song X; Liu ME; Li XK; Shan CX; Qiu M
J Surg Res; 2014 Sep; 191(1):123-9. PubMed ID: 24768143
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Gastric Bypass with a Distal Gastric Pouch on Glucose Tolerance and Diabetes Remission in Type 2 Diabetes Sprague-Dawley Rat Model.
Dolo PR; Shao Y; Li C; Zhu X; Yao L; Wang H
Obes Surg; 2019 Jun; 29(6):1889-1900. PubMed ID: 30778846
[TBL] [Abstract][Full Text] [Related]
11. Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass.
Jonsson I; Bojsen-Møller KN; Kristiansen VB; Veedfald S; Wewer Albrechtsen NJ; Clausen TR; Kuhre RE; Rehfeld JF; Holst JJ; Madsbad S; Svane MS
Front Endocrinol (Lausanne); 2021; 12():681116. PubMed ID: 34084153
[TBL] [Abstract][Full Text] [Related]
12. GK-rats respond to gastric bypass surgery with improved glycemia despite unaffected insulin secretion and beta cell mass.
Miskelly MG; Shcherbina L; Thorén Fischer AH; Abels M; Lindqvist A; Wierup N
Peptides; 2021 Feb; 136():170445. PubMed ID: 33197511
[TBL] [Abstract][Full Text] [Related]
13. Does the hepatic branch of vagus mediate the secretion of glucagon-like peptide-1 during the Roux-en-Y gastric bypass surgery?
Qiu NC; Liu ME; Wang B; Song X; Jiang Y; Wang J; Gu ZQ; Shan CX; Qiu M
J Gastrointest Surg; 2014 Nov; 18(11):1957-64. PubMed ID: 25183408
[TBL] [Abstract][Full Text] [Related]
14. The Leading Role of Peptide Tyrosine Tyrosine in Glycemic Control After Roux-en-Y Gastric Bypass in Rats.
Camacho-Ramírez A; Prada-Oliveira JA; Ribelles-García A; Almorza-Gomar D; Pérez-Arana GM
Obes Surg; 2020 Feb; 30(2):697-706. PubMed ID: 31701411
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of IRS-1 expression in Goto-Kakizaki rats following Roux-en-Y gastric bypass surgery: resolution of type 2 diabetes?
Li SQ; Zhou Y; Wang Y; Liu Y; Geng DH; Liu JG
Tohoku J Exp Med; 2011 Nov; 225(3):179-86. PubMed ID: 22001674
[TBL] [Abstract][Full Text] [Related]
16. Roux-en-Y gastric bypass increases hepatic and peripheral insulin sensitivity in rats with type 2 diabetes mellitus.
He B; Chen L; Yu C; Piao D; Wang Y; Han P
Surg Obes Relat Dis; 2014; 10(3):485-93. PubMed ID: 24503104
[TBL] [Abstract][Full Text] [Related]
17. Down-Regulation of Renal Gluconeogenesis in Type II Diabetic Rats Following Roux-en-Y Gastric Bypass Surgery: A Potential Mechanism in Hypoglycemic Effect.
Wen Y; Lin N; Yan HT; Luo H; Chen GY; Cui JF; Shi L; Chen T; Wang T; Tang LJ
Obes Facts; 2015; 8(2):110-24. PubMed ID: 25832593
[TBL] [Abstract][Full Text] [Related]
18. Roux-en-Y gastric bypass attenuates the progression of cardiometabolic complications in obese diabetic rats via alteration in gastrointestinal hormones.
Lau RG; Kumar S; Hall CE; Palaia T; Rideout DA; Hall K; Brathwaite CE; Ragolia L
Surg Obes Relat Dis; 2015; 11(5):1044-53. PubMed ID: 25980330
[TBL] [Abstract][Full Text] [Related]
19. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
[TBL] [Abstract][Full Text] [Related]
20. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
Rohde U
Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]